Cancer Cell International | |
Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis | |
Ping Zhang1  Peng Xu1  Nan Zhang2  Zhi-Gang Sun3  Kang Hu4  | |
[1] Cheeloo College of Medicine, Shandong University, 250013, Jinan, Shangdong, China;Department of Oncology, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, 250013, Jinan, Shangdong, China;Department of Thoracic Surgery, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, 250013, Jinan, Shangdong, China;School of Clinical Medicine, Weifang Medical University, 261053, Weifang, Shangdong, China; | |
关键词: YTHDF2; Hypoxia; mTOR/AKT; EMT; METTL14; LUSC; | |
DOI : 10.1186/s12935-021-02368-y | |
来源: Springer | |
【 摘 要 】
BackgroundN6-methyladenosine (m6A) is a dynamic and reversible internal RNA structure of eukaryotic mRNA. YTH domain family 2 (YTHDF2), an m6A-specific reader YTH domain family, plays fundamental roles in several types of cancer. However, the function of YTHDF2 in lung squamous cell carcinoma (LUSC) remains elusive.MethodsThe knockdown and overexpression of YTHDF2 in LUSC cells were conducted to detect the biological characteristics of YTHDF2. In vivo assays, the role of YTHDF2 in tumor growth was further uncovered. In vitro assays, YTHDF2 was confirmed to be involved in activating the mTOR/AKT signaling and YTHDF2 overexpression induced the EMT process in LUSC. Clinically, immunohistochemical staining revealed the relationship between YTHDF2 expression levels and the clinicopathological characteristics of lung squamous cell carcinoma patients. Moreover, quantitative PCR (qPCR), western blot, CCK8 assay, transwell assay, and wound-healing assay were used to detect the expression level and function of YTHDF2 under hypoxia exposure in LUSC cells.ResultsThe results showed that hypoxia-mediated YTHDF2 overexpression promotes cell proliferation and invasion by activating the mTOR/AKT axis, and YTHDF2 overexpression induces the EMT process in LUSC. Moreover, YTHDF2 is closely associated with pN (pN– 37.0%, pN + 73.9%; P = 0.002) and pTNM stage (pI 50.0%, PII 43.3%, pIIIa 80.6%; P = 0.007), ultimately resulting in poor survival for LUSC patients.ConclusionIn brief, the results highlight high-YTHDF2 expression predicted a worse prognosis of LUSC, while hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT signaling pathway.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202203113907889ZK.pdf | 2201KB | download |